Research funding propels Memphis college in national rank
A college at the University of Tennessee Health Science Center (UTHSC) has received national recognition for its research.
UTHSC In the Media
Cincinnati surgeon takes helm of Le Bonheur’s surgery division
Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center (UTHSC) have named a new surgery chief.
Dr. Jason S. Frischer named Surgeon-in-Chief and Chief of Pediatric Surgery at Le Bonheur Children’s and UT Health Science Center
Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center (UTHSC) are proud to announce the appointment of Jason S. Frischer, MD, as Surgeon-in-Chief and Chief of Pediatric Surgery.
Dr. Jason S. Frischer named Surgeon-in-Chief and Chief of Pediatric Surgery at Le Bonheur Children’s and UT Health Science Center
Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center (UTHSC) are proud to announce the appointment of Jason S. Frischer, MD, as Surgeon-in-Chief and Chief of Pediatric Surgery.
Dr. Jason S. Frischer named Surgeon-in-Chief and Chief of Pediatric Surgery at Le Bonheur Children’s and UT Health Science Center
Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center (UTHSC) are proud to announce the appointment of Jason S. Frischer, MD, as Surgeon-in-Chief and Chief of Pediatric Surgery.
Memphis City Council requests meeting to reconsider building new Regional One facility
Memphis City Council members voted Tuesday to ask the Shelby County mayor and commission to hold a meeting to reconsider building the new Regional One Health facility.
RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures
RevBio, Inc., announced that it has been awarded a $2.2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH).
RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures
This Grant will Advance the Company’s Preclinical Research to Demonstrate an Improvement to the Current Standard of Care for Treating Vertebral Compression Fractures